Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

BerGenBio doses first patient in second part of BGBC008 trial

Small-cell lung carcinoma with an unusual degree of cellular pelomorphism. Credit: Yale Rosen.



Go Top